Gabmedis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 804,011 | 718,920 | 652,893 | 456,770 | 396,909 | 711,633 | 829,475 | 945,572 |
| Profit before tax | 5,570 | 111,967 | 68,131 | 172,340 | 29,894 | 101,834 | 204,343 | 392,075 |
| Net profit | 4,592 | 94,800 | 57,896 | 152,328 | 25,216 | 85,948 | 178,976 | 346,131 |
| Equity | 1,152,434 | 1,237,934 | 1,284,931 | 1,437,259 | 1,454,875 | 1,536,021 | 1,595,437 | 1,732,972 |
| Liabilities | 15,699 | 21,203 | 14,995 | 43,340 | 12,103 | 27,003 | 35,215 | 36,473 |
| Non-current assets | 338,839 | 225,758 | 191,391 | 420,039 | 409,666 | 444,510 | 483,370 | 451,653 |
| Current assets | 829,294 | 1,033,379 | 1,107,322 | 1,093,014 | 1,081,174 | 1,132,787 | 1,154,216 | 1,319,528 |
| Total assets | 1,168,133 | 1,259,137 | 1,298,713 | 1,513,053 | 1,490,840 | 1,577,297 | 1,637,586 | 1,771,181 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 47,130 | 104,002 | 141,196 |
| Social insurance contributions | - | - | - | - | - | 13,917 | 14,674 | 16,298 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -31.1% | -10.6% | -9.2% | -30.0% | -13.1% | +79.3% | +16.6% | +14.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.4% | 7.5% | 4.5% | 10.1% | 1.7% | 5.4% | 10.9% | 19.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.4% | 7.7% | 4.5% | 10.6% | 1.7% | 5.6% | 11.2% | 20.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.6% | 13.2% | 8.9% | 33.3% | 6.4% | 12.1% | 21.6% | 36.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.7% | 15.6% | 10.4% | 37.7% | 7.5% | 14.3% | 24.6% | 41.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 89,335 | 105,208 | 126,366 | 88,407 | 66,152 | 118,606 | 138,246 | 157,595 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gabmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-11-17 | 2022-11-18 | 0.16 |
| 2022-10-28 | 2022-10-30 | 0.16 |
| 2022-09-16 | 2022-09-19 | 104.65 |
Gabmedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 366.97 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gabmedis, UAB (code 178847695) is a Private Limited Liability Company engaged in logging. In 2025, the company generated revenue of EUR 945.6K, up 14.0% year on year and 32.9% over two years, showing a steady expansion path from EUR 711.6K in 2023 to EUR 829.5K in 2024 and EUR 945.6K in 2025. Net profit also increased strongly, from EUR 85.9K in 2023 to EUR 179.0K in 2024 and EUR 346.1K in 2025, with the profit margin rising from 12.1% to 21.6% and then 36.6%. The balance sheet remained solid, with total assets of EUR 1.77M, equity of EUR 1.73M and liabilities of only EUR 36.5K in 2025. The equity ratio was 97.8%, and debt-to-equity stood at 0.02, indicating very limited leverage. Return on equity was 20.0% and return on assets 19.5%, while asset turnover was 0.53x. Revenue per employee reached EUR 157.6K and profit per employee EUR 57.7K, suggesting efficient operations in the latest year.